ORBIMED CAPITAL LLC

CIK 1157524 · last filed 2026-04-23

ORBIMED CAPITAL LLC is a corporate insider who has filed 15 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing shows the insider bought $50.0M of PRLD on Apr 23, 2026. Across all open-market trades the lifetime net is +$39.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $98.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$98.03M

Companies

7

Total Filings

15

Lifetime Open-Market Net

$39.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRLD Director 1,126,126 $4.49 $5.06M $65.00M 3 2026-04-23
SPRY Director 269,323 $9.76 $2.63M -$3.26M 1 2024-08-28
Kinnate Biopharma Inc. (KNTE) Delisted Director 1,368,339 $2.65 $3.63M $36.56M 3 2023-05-08
ARQT Director 3,534,537 $24.38 $86.17M $43.84M 3 2022-06-28
PMVP 10%+ Owner 109,500 $1.11 $121.5K -$41.06M 1 2022-03-31
Repare Therapeutics Inc. (RPTX) Delisted Director 3,221,637 $2.65 $8.54M -$1.85M 1 2021-08-30
ALEC Director 2,650,781 $1.53 $4.06M -$60.17M 3 2019-12-26

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-23 PRLD Buy (P) +11,261,260 $50.00M EDGAR
2024-08-28 SPRY Sell (S) −251,085 -$3.26M EDGAR
2023-05-24 PRLD Buy (P) +2,608,695 $15.00M EDGAR
2023-05-08 Kinnate Biopharma Inc. (KNTE) Delisted Buy (P) +10,226,524 $28.60M EDGAR
2022-06-28 ARQT Sell (S) −1,025,913 -$21.86M EDGAR
2022-03-31 PMVP Sell (S) −1,898,000 -$41.06M EDGAR
2022-02-15 Kinnate Biopharma Inc. (KNTE) Delisted Buy (P) +782,800 $7.96M EDGAR
2021-08-30 Repare Therapeutics Inc. (RPTX) Delisted Sell (S) −54,219 -$1.85M EDGAR
2021-01-12 PRLD Buy (P) $0 EDGAR
2020-12-09 Kinnate Biopharma Inc. (KNTE) Delisted Conv (C) +12,391,716 $0 EDGAR
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.